Skip to content

Glycated Hemoglobin Controls

by Primus Corp.

510(k) K940143

Glycated Hemoglobin Controls is a medical device (FDA Class II; FDA product code LCP, Assay, Glycosylated Hemoglobin) made by Primus Corp., cleared under FDA 510(k) K940143 on 15 Mar 1994, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK940143 Date15 Mar 1994ClearedStatusActive

Official records

From the FDA record

Received by the FDA
11 Jan 1994
FDA decision
15 Mar 1994 (Substantially Equivalent)
FDA review time
63 days from receipt to decision
Public document
510(k) statement on file with the FDA

From the FDA 510(k) record K940143 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
LCP
Device class
Class II
Regulation
21 CFR Part 864.7470
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code LCP (Assay, Glycosylated Hemoglobin).

Other devices from Primus Corp.

See all devices from Primus Corp. →